SB 159 (see companion bill HB 462) – MarylandStatus: Inactive / Dead
Year Introduced: 2022
Requiring each authorized prescriber who receives a financial gratuity or incentive from a pharmaceutical distributor or manufacturer to file a disclosure form with a certain health occupations board that licenses the authorized prescriber within 30 days after the financial gratuity or incentive is received by the authorized prescriber; and applying the Act prospectively
Key Issues: PHARMACEUTICALS Competition HEALTHCARE MARKETS
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
No items found